Multitarget stool DNA tests — which are becoming more popular in the United States — have shown increased sensitivity over fecal immunochemical tests (FITs) for early colorectal cancer (CRC) screening ...

The study supports colorectal cancer (CRC) screening initiation at age 45, aligning with US Preventive Services Task Force guidelines due to increased CRC prevalence in younger patients. Patients aged ...

In July, the US Food and Drug Administration (FDA) approved a new blood-based test to screen for colorectal cancer (CRC). The FDA's approval of Shield (Guardant Health) marks a notable achievement, as ...

By reducing the level at which traces of blood in a FIT test trigger further investigation – from 120 micrograms of blood per gram of poo down to 80 – the NHS will offer 35% more screening ...

Combining mailed FIT outreach with patient navigation increased CRC screening rates among rural Medicaid enrollees. The intervention group showed a higher CRC screening completion rate compared to ...

Results from a new JAMA Network study support the large-scale use of FIT tests. The findings show that those who complete one or more fecal immunochemical test (FIT) screenings are associated with a ...

Doctors can provide alternative forms of screening for colon and rectal cancer but sometimes have a good reason to stick with the colonoscope. By Gina Kolata This year about 53,000 Americans are ...